Non-Small Cell Lung Cancer
|
Development Stage
|
Early Development
|
|
U.S. Incidence of Non-Small Cell Lung Cancer1
|
160,000/Year
|
|
Global Incidence of Non-Small Cell Lung Cancer2
|
1.2 Million/Year
|
About Non-Small Cell Lung Cancer Treatment and Genomic Health's Products in Development
Lung cancer is a condition where there is uncontrolled growth of cells in the lungs.
It is the most common cause of cancer-related death in both men and women.3
Exposure to tobacco smoke is by far the most common cause of lung cancer, but lung
cancer diagnosis is not limited to smokers. The term "non-small cell lung cancer"
refers to how the involved cells look under the microscope (another type of lung
cancer is known as "small cell lung cancer"). Non-small cell lung cancer includes
squamous cell carcinoma, large cell carcinoma and adenocarcinoma. Non-small cell
lung cancer is the most common kind of lung cancer. Current lung cancer treatments
include surgery,
chemotherapy and/or radiation. A test which would provide insight into the
individual biology and behavior following diagnosis is greatly needed to better
inform treatment planning for lung cancer patients and their physicians. Genomic
Health is working to develop such tests.
Learn more about additional Genomic Health products in development:
For more information about lung cancer diagnosis, visit the National Cancer Institute's
Lung Cancer
page or the non-profit group lungcancer.org.
Relevant Presentations
2003 ASCO Annual Meeting—Chicago, IL
Abstract #763: Oral Presentation
Quantitative Gene
Expression in Non-Small Cell Lung Cancer from Paraffin-Embedded Tissue Specimens:
Predicting Response to Gefitinib, an EGFR Kinase Inhibitor
RB Natale, S Shak, N Aronson, S Averbuch, W Fox, D Luthringer, K Clark, J Baker,
M Cronin, DB Agus
- MattsonJack DaVinci ©2004, 2007.
- Globocan 2002/ACS Cancer Facts & Figures, 2007.
- American Cancer Society 2007 Statistics. Available at: http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf.
Accessed July 22, 2008.